- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04911803
Self-help App and Wellbeing
Does Using a Self-help App to Improve Wellbeing Work? - An Experimental Follow-up Study
Anxiety and worry are amongst the most common mental health difficulties. The Second Mental Health Study found a significant increase in the lifetime prevalence for GAD, from 0.9% to 1.6%. In addition, the Organisation for Economic Cooperation and Development found that among Singaporean students, 86% experienced anxiety levels that were significantly higher than the OECD average.
Past research revealed that individuals who worried more experienced decreases in life satisfaction. It was also found that worry and anxiety are significant predictors of one's psychological wellbeing .
In line with this trend, the market for wellbeing apps have been one of the fastest growing categories of apps ever since; with more than 10,000 on the market. Studies have shown that the use of wellbeing apps has been correlated with an improvement in mental wellbeing. However, due to the lack of research that focuses on disorder-specific evidence, there still exists debates around the effectiveness of wellbeing apps on anxiety and worry. In addition, the lack of research on the mediating factor of psychological mindedness in the relationship between the use of wellbeing apps and mental well-being, could be pivotal to the effectiveness of wellbeing apps.
To show the effectiveness of evidence-based wellbeing apps in targeting anxiety and worry, this study will employ the engagement of participants with a wellbeing app for a controlled period of 2 weeks before recording their mental wellbeing outcomes.This paradigm has been replicated extensively through multiple studies.
This study will use a between-groups experimental study design whereby participants will be block randomised into 2 conditions: Active control condition, and Anxiety condition. Each condition will be given a restricted version of the wellbeing app according to their treatment groups. Follow-up data will be collected at 2-weeks post intervention to establish efficacy of the intervention.
Objective 1: To evaluate the effectiveness of a wellbeing app self-help programme for reducing anxiety and worry.
Objective 2: To examine if psychological mindedness moderates hypothesised effects of wellbeing app usage and anxiety and worry.
Hypothesis 1: Participants in the intervention group will report significantly lower anxiety and worry than participants in the control group.
Hypothesis 2: Psychological mindedness will moderate the effect of the wellbeing app's self-help programme on anxiety and worry: Participants high in psychological mindedness will benefit more from the wellbeing apps than those with lower scores on psychological mindedness.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 119077
- National University of Singapore
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 18 years old for NUS students, or 21 for non NUS students
Exclusion Criteria:
- Participants who do not meet the age requirement
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Anxiety Group
Participants will download the anxiety application to their own handphones, and will complete the programme subsequently in their own time over the course of 2 weeks.
The expected duration participants will spend on the anxiety application daily is estimated to be around 5 to 10 minutes, amounting to a total of around 140 minutes (2 hours and 10 minutes) during the 2 weeks intervention.
Participants in the anxiety group are asked to complete daily brief exercises.
For example, they will practice noticing worry thoughts and journal them down.
|
The Intellect mobile app (containing the anxiety application) can be freely downloaded from the App store and Google Play store for free.
The app provides access to the different programmes.
The mobile app has been pilot tested by Intellect before the release on the App and Google Play store.
However, for this research project Intellect is going to provide the the programmes as stand alone applications exclusively for the participants of this research.
|
Active Comparator: Procrastination Group
Participants will download the procrastination application to their own handphones, and will complete the programme subsequently in their own time over the course of 2 weeks.
The expected duration participants will spend on the procrastination application daily is estimated to be around 5 to 10 minutes, amounting to a total of around 140 minutes (2 hours and 10 minutes) during the 2 weeks intervention.
Participants in the procrastination group are asked to complete daily brief exercises.
For example, they will practice to reduce procrastination-related thoughts.
|
The Intellect mobile app (containing the procrastination application) can be freely downloaded from the App store and Google Play store for free.
The app provides access to the different programmes.
The mobile app has been pilot tested by Intellect before the release on the App and Google Play store.
However, for this research project Intellect is going to provide the the programmes as stand alone applications exclusively for the participants of this research.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
General Anxiety Disorder - 7 (GAD-7)
Time Frame: Measured before the intervention
|
General Anxiety Disorder- 7 (GAD-7) is a 7 item self report instrument that measures anxiety and is widely used in research in clinical and nonclinical practices anxiety as a continuum (Siddaway, Taylor & Wood, 2018) and is a reliable and valid instrument for assessing anxiety in a general population (Löwe et al., 2008).
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
GAD-7 produced an excellent internal consistency of α=0.92 in a sample of 2982 participants (Spitzer, Kroenke, Williams, & Löwe, 2006).
|
Measured before the intervention
|
General Anxiety Disorder - 7 (GAD-7)
Time Frame: 1-2 days after completing the intervention (2 weeks)
|
General Anxiety Disorder- 7 (GAD-7) is a 7 item self report instrument that measures anxiety and is widely used in research in clinical and nonclinical practices anxiety as a continuum (Siddaway, Taylor & Wood, 2018) and is a reliable and valid instrument for assessing anxiety in a general population (Löwe et al., 2008).
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
GAD-7 produced an excellent internal consistency of α=0.92 in a sample of 2982 participants (Spitzer, Kroenke, Williams, & Löwe, 2006).
|
1-2 days after completing the intervention (2 weeks)
|
General Anxiety Disorder - 7 (GAD-7)
Time Frame: 2 weeks after the completion of the intervention
|
General Anxiety Disorder- 7 (GAD-7) is a 7 item self report instrument that measures anxiety and is widely used in research in clinical and nonclinical practices anxiety as a continuum (Siddaway, Taylor & Wood, 2018) and is a reliable and valid instrument for assessing anxiety in a general population (Löwe et al., 2008).
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
GAD-7 produced an excellent internal consistency of α=0.92 in a sample of 2982 participants (Spitzer, Kroenke, Williams, & Löwe, 2006).
|
2 weeks after the completion of the intervention
|
Patient Health Questionnaire - 9 (PHQ-9)
Time Frame: Measured before the intervention
|
Patient Health Questionnaire (PHQ-9) i s a 9 item self report instrument that measures depression.
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
In a sample of 3000 patients in the PHQ Primary Care Study, PHQ-9 achieved an excellent internal consistency of α=0.89 (Kroenke, Spitzer, & Williams, 2001).
|
Measured before the intervention
|
Patient Health Questionnaire - 9 (PHQ-9)
Time Frame: 1-2 days after completing the intervention (2 weeks)
|
Patient Health Questionnaire (PHQ-9) i s a 9 item self report instrument that measures depression.
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
In a sample of 3000 patients in the PHQ Primary Care Study, PHQ-9 achieved an excellent internal consistency of α=0.89 (Kroenke, Spitzer, & Williams, 2001).
|
1-2 days after completing the intervention (2 weeks)
|
Patient Health Questionnaire - 9 (PHQ-9)
Time Frame: 2 weeks after the completion of the intervention
|
Patient Health Questionnaire (PHQ-9) i s a 9 item self report instrument that measures depression.
Items are scored on a 4-point scale, ranging from "not at all (0)", "several days (1)", "more than half the days (2)" and "nearly everyday (3)".
In a sample of 3000 patients in the PHQ Primary Care Study, PHQ-9 achieved an excellent internal consistency of α=0.89 (Kroenke, Spitzer, & Williams, 2001).
|
2 weeks after the completion of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological Mindedness Scale
Time Frame: Measured before the intervention
|
Psychological Mindedness Scale (PM): 45 item self report instrument that measures an individual's ability to be reflective about interpersonal relationships, psychological processes and meanings across both intellectual and emotional dimensions.
Items are scored on a 4 point-scale ranging from "strongly agree (4)" to "strongly disagree (1)".
The PM has a good internal consistency of α= 0.86 and recomputed to 0.87 in a study of 256 patients (Conte et al., 1990).
|
Measured before the intervention
|
App Engagement Scale
Time Frame: Measured 1-2 days after completing the intervention (2 weeks)
|
App Engagement Scale (AES): 7 item self report feedback instrument that indicates the degree to which an individual engages with an app.
Items are scored on a 5 point-scale ranging from "strongly agree (5)" to "strongly disagree (1)".
This App Engagement Scale had good internal reliability, Cronbach's α = .839
in a study of 1349 app user (Rickard & Bakker, 2019).
|
Measured 1-2 days after completing the intervention (2 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Oliver Suendermann, National University of Singapore
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NUS-IRB-2021-266
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety and Worry
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR)Completed
-
National Taiwan University HospitalTerminated
-
Sandraluz Lara-CinisomoCompletedStress, Depression, Anxiety and WorryUnited States
-
Karolinska InstitutetRegion StockholmCompleted
-
Karolinska InstitutetCompleted
-
Queen's University, BelfastUniversity College Dublin; Exceed WorldwideCompletedMental Health | Distress, Emotional | WorryCambodia
-
Karolinska InstitutetCompleted
-
Babes-Bolyai UniversityCompletedPsychological Distress | Worry | Career Decision-making DifficultiesRomania
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioCompletedExcessive WorryCanada
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR); Ministry of Research, Innovation...UnknownExcessive WorryCanada
Clinical Trials on Anxiety Application
-
Ataturk UniversityCompletedQuality of Life | Anxiety Level | Perceived StressTurkey
-
Universidad Católica San Antonio de MurciaNot yet recruitingPhysical Activity | Adolescent Behavior | New Technologies
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vanderbilt... and other collaboratorsActive, not recruitingNephrectomy | Kidney | Living DonorsUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Assiut UniversityCompletedImproving Quality of LifeEgypt
-
Ataturk Training and Research HospitalNot yet recruiting
-
TC Erciyes UniversityCompleted
-
patientMpower Ltd.Health Service Executive, IrelandCompleted
-
Kars State HospitalCompletedExercise | Ultrasound | KinesiotapeTurkey
-
University of North Carolina, Chapel HillCompleted